Bayer Aktiengesellschaft

  • WKN: BAY001
  • ISIN: DE000BAY0017
  • Land: Deutschland

Nachricht vom 08.05.2019 | 10:51

Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Bayer Aktiengesellschaft

08.05.2019 / 10:51
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Notification of Major Holdings

1. Details of issuer
Name: Bayer Aktiengesellschaft
Street: Kaiser-Wilhelm-Allee 1
Postal code: 51373
City: Leverkusen
Germany
Legal Entity Identifier (LEI): 549300J4U55H3WP1XT59

2. Reason for notification
  Acquisition/disposal of shares with voting rights
X Acquisition/disposal of instruments
  Change of breakdown of voting rights
  Other reason:

3. Details of person subject to the notification obligation
Legal entity: The Goldman Sachs Group, Inc.
City of registered office, country: Wilmington, Delaware, United States of America (USA)

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
 

5. Date on which threshold was crossed or reached:
03 May 2019

6. Total positions
  % of voting rights attached to shares
(total of 7.a.)
% of voting rights through instruments
(total of 7.b.1 + 7.b.2)
Total of both in %
(7.a. + 7.b.)
Total number of voting rights pursuant to Sec. 41 WpHG
New 0.07 % 0.22 % 0.29 % 932551964
Previous notification 1.76 % 3.70 % 5.46 % /

7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN Absolute In %
  Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
DE000BAY0017 553303 % 0.06 %
US0727303028 60622 % 0.01 %
Total 613925 0.07 %

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
Securities Lending open 228774 0.02 %
    Total 228774 0.02 %

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
Swap 31.12.2030 Cash 873941 0.09 %
Call Warrant 31.12.2030 Cash 462540 0.05 %
Put Warrant 31.12.2030 Cash 288700 0.03 %
CFD 22.03.2029 Cash 135101 0.01 %
Call Option 21.06.2019 Physical 58872 0.01 %
Swap 19.03.2021 Physical 7833 0.001 %
Call Warrant 19.03.2021 Physical 3827 0.0004 %
      Total 1830814 0.20 %

8. Information in relation to the person subject to the notification obligation
  Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)
The Goldman Sachs Group, Inc. % % %
GSAM Holdings LLC % % %
Goldman Sachs Asset Management, L.P. % % %
 
The Goldman Sachs Group, Inc. % % %
Goldman Sachs & Co. LLC % % %
 
The Goldman Sachs Group, Inc. % % %
Goldman Sachs (UK) L.L.C. % % %
Goldman Sachs Group UK Limited % % %
Goldman Sachs International % % %
 
The Goldman Sachs Group, Inc. % % %
Goldman, Sachs & Co. Wertpapier GmbH % % %

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights Proportion of instruments Total of both
% % %

10. Other explanatory remarks:
 

Date
07 May 2019



08.05.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC-Fokusbox

Expedeon AG mit attraktiver Produktpipeline

Durch die konsequente Fortsetzung der „Grow, Buy & Build“-Strategie hat die im Bereich der Entwicklung und Vermarktung von DNA-Technologien, Proteomik- und Antikörper-Konjugations-Anwendungen tätige Expedeon AG das Umsatzniveau angehoben und auf operativer Ergebnisebene zugleich den Break-Even nachhaltig überschritten. Für die kommenden Perioden ist der Ausbau der Umsatzerlöse mit den bestehenden Produkten geplant. Darüber hinaus verfügt die Expedeon AG über eine attraktive Produktpipeline mit hohem Umsatzpotenzial. Unser Kursziel liegt bei 3,20 € je Aktie. Das Rating lautet KAUFEN.

Aktuelle Research-Studie

Schweizer Electronic AG

Original-Research: Schweizer Electronic AG (von Montega AG): Kaufen

14. Oktober 2019